|Articles|July 26, 2018
Linical and Accelovance Merge Under New Linical Name
Advertisement
Linical and Accelovance merged to create a global CRO with a significant footprint across North America, Europe and Asia-Pacific. Under this merger, they will be called Linical and have appointed a new CEO, Vita M. Lanoce. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
Balancing Innovation and Compliance under New GCP Guidelines
4
Obesity Trials: Scaling Operations for High-Demand Therapeutics
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
